Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones : implications and future research

Jairoun, Ammar Abdulrahman and Al-hemyari, Sabaa Saleh and El-Dahiyat, Faris and Shahwan, Moyad and Zyoud, Sa'ed H and Abu-Gharbieh, Eman and Suaifan, Ghadeer and Godman, Brian and Kurdi, Amanj (2023) Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones : implications and future research. Research in Social and Administrative Pharmacy, 19 (4). pp. 569-572. ISSN 1551-7411 (https://doi.org/10.1016/j.sapharm.2023.01.009)

[thumbnail of Jairoun-etal-RSAP-2023-Shedding-light-on-community-pharmacist-directed]
Preview
 Text. Filename: Jairoun_etal_RSAP_2023_Shedding_light_on_community_pharmacist_directed.pdf
Accepted Author Manuscript
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo
Download (720kB)| Preview

Abstract

Kidney function reduces progressively from age 30 as part of the normal aging process, with a decline in function of around 1 mL/min, which accelerates after age 65 [1, 2]. A silent kidney disease, kidney stones (KS) can develop in this population, occupying the hollow spaces inside the kidney. Comprising hard salt or mineral deposits, KS can occasionally remain inside the kidney and cause no complications [3]. KS are most commonly made of calcium, but uric acid, struvite, and cystine stones can also occur [3]. Globally, the rate of KS development is growing, with the US reporting a prevalence of 8.8% in 2012

CORE (COnnecting REpositories)